my take, page-5

re: us the sheep................. "Of course there will be critcism of the FDA TGA rejections, but certainly as far as FDA is concerned the 501k route was the best way to go."
Well if you think a 12 month delay after management for the last six months has been promoting approvals from both before xmas then you are obviously one of the sheep and me included before I woke up to a litany of indiscretions with this stock.

PS - who is going to pay the administrative costs and clinical costs over the next 12 months - you've guessed it another capital raising - with no FDA approval as security the insto's are going to screw CCE on an issue price certainly well below whatever the market value is at that time